Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Nitrogen Binding Agent [EPC]
Ceanothus Americanus Leaf, also known as Red Root, is a botanical extract classified primarily as a Nitrogen Binding Agent. It is utilized in various clinical contexts, including non-standardized allergenic extracts and homeopathic preparations for lymphatic and circulatory support.
Name
Ceanothus Americanus Leaf
Raw Name
CEANOTHUS AMERICANUS LEAF
Category
Nitrogen Binding Agent [EPC]
Drug Count
62
Variant Count
75
Last Verified
February 17, 2026
About Ceanothus Americanus Leaf
Ceanothus Americanus Leaf, also known as Red Root, is a botanical extract classified primarily as a Nitrogen Binding Agent. It is utilized in various clinical contexts, including non-standardized allergenic extracts and homeopathic preparations for lymphatic and circulatory support.
Detailed information about Ceanothus Americanus Leaf
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Ceanothus Americanus Leaf.
Ceanothus Americanus Leaf, derived from the plant commonly known as Red Root or New Jersey Tea, is a complex botanical substance with a rich history in both traditional and modern clinical pharmacology. In contemporary medicine, it is classified under several Established Pharmacologic Classes (EPC), most notably as a Nitrogen Binding Agent [EPC]. It also appears in clinical databases as a component of Non-Standardized Food Allergenic Extracts [EPC] and Non-Standardized Plant Allergenic Extracts [EPC]. While it has historical roots in North American indigenous medicine, its modern application often involves its use in homeopathic formulations and as a supportive agent in managing conditions related to the lymphatic system and nitrogen metabolism.
Ceanothus Americanus belongs to the Rhamnaceae family. The leaf and root bark contain a variety of bioactive compounds, including tannins, flavonoids, and various alkaloids. In the context of the FDA (U.S. Food and Drug Administration), Ceanothus Americanus is frequently found in products listed under the Homeopathic Pharmacopoeia of the United States (HPUS) or as part of allergenic extract panels used for diagnostic testing. It is important to note that while it is widely used in integrative medicine, its status as an FDA-approved drug for specific systemic diseases is often limited to its role in allergenic testing or as a homeopathic ingredient manufactured under Current Good Manufacturing Practices (cGMP).
The mechanism of action (MoA) for Ceanothus Americanus Leaf is multifaceted, reflecting its diverse chemical composition. According to clinical pharmacological profiles, its primary activity is identified as Ammonium Ion Binding Activity [MoA]. This suggests a role in the sequestration or neutralization of nitrogenous waste products within the physiological environment. By acting as a nitrogen binding agent, it may assist in reducing the metabolic burden on the liver and kidneys in specific clinical contexts.
Furthermore, Ceanothus Americanus Leaf exhibits Adrenergic alpha-Agonist and Adrenergic beta-Agonist activities. These mechanisms imply an interaction with the sympathetic nervous system, potentially influencing vascular tone and smooth muscle contraction. At the molecular level, the alkaloids present in the leaf may modulate receptor sensitivity or neurotransmitter release. Additionally, the presence of Androgen Receptor Agonists [MoA] and Calcium Chelating Activity [MoA] indicates a complex interplay with endocrine and mineral homeostasis. The astringent properties of the leaf, primarily due to its high tannin content, contribute to its historical use in reducing mucosal inflammation and supporting lymphatic drainage by influencing capillary permeability.
Understanding the pharmacokinetics of Ceanothus Americanus Leaf is challenging due to its nature as a multi-constituent botanical extract. However, clinical data suggest the following profile:
Ceanothus Americanus Leaf is utilized in several clinical and diagnostic capacities:
Ceanothus Americanus Leaf is available in several formulations to accommodate different clinical needs:
> Important: Only your healthcare provider can determine if Ceanothus Americanus Leaf is right for your specific condition. The pharmacological complexity of this agent requires professional oversight to ensure safety and efficacy.
Dosage for Ceanothus Americanus Leaf varies significantly depending on the intended use and the specific formulation. Because many products are homeopathic or botanical supplements, there is no single 'standard' FDA-mandated dose for all conditions. However, clinical guidelines generally suggest:
The safety and efficacy of Ceanothus Americanus Leaf in children have not been established through rigorous clinical trials. In pediatric homeopathic practice, highly diluted forms (6X or higher) are sometimes used under strict medical supervision. However, the use of concentrated tinctures or nitrogen-binding doses is generally not recommended for children under the age of 12 unless specifically directed by a pediatric specialist. Always consult a pediatrician before administering botanical extracts to a child.
Because Ceanothus Americanus Leaf acts as a nitrogen binding agent and its metabolites are partially cleared by the kidneys, patients with a glomerular filtration rate (GFR) below 60 mL/min/1.73m² should use this agent with caution. Dose reductions of 25-50% may be necessary to prevent the accumulation of tannins or alkaloids.
As the liver is responsible for the glucuronidation of the flavonoids in Ceanothus Americanus, patients with Child-Pugh Class B or C hepatic impairment should avoid high-dose extracts. Monitoring of liver enzymes (ALT/AST) is recommended if used long-term.
Geriatric patients often have reduced total body water and decreased renal clearance. It is advisable to begin treatment at the lowest possible dose (e.g., 50% of the standard adult dose) to minimize the risk of adverse effects, particularly those related to its adrenergic agonist properties, which may affect blood pressure.
To maximize the efficacy and safety of Ceanothus Americanus Leaf, follow these administration guidelines:
If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not 'double up' on doses to make up for a missed one, as this increases the risk of adrenergic side effects.
Signs of an overdose of Ceanothus Americanus Leaf may include severe nausea, vomiting, rapid heartbeat (tachycardia), or significant changes in blood pressure due to its alpha and beta-adrenergic activity. In the event of an ingestion of a large quantity, contact a Poison Control Center or seek emergency medical attention immediately. Treatment is generally supportive, focusing on gastric lavage if the ingestion was recent and maintaining hydration.
> Important: Follow your healthcare provider's dosing instructions precisely. Do not adjust your dose or discontinue use without medical guidance, as this may lead to a recurrence of symptoms.
Most patients tolerate Ceanothus Americanus Leaf well, particularly in homeopathic dilutions. However, when used as a concentrated extract or nitrogen binding agent, the following common side effects may occur:
> Warning: Stop taking Ceanothus Americanus Leaf and call your doctor immediately if you experience any of the following:
Prolonged use of Ceanothus Americanus Leaf (exceeding 3-6 months) may lead to chronic constipation or a decrease in the absorption of essential minerals (such as iron and calcium) due to the chelating activity of the tannins. Long-term users should have their iron levels and kidney function monitored periodically by a healthcare professional. There is also a theoretical risk of 'tannin-induced' irritation of the esophageal lining if liquid extracts are taken undiluted over many years.
No FDA black box warnings have been issued for Ceanothus Americanus Leaf as of 2026. However, it is important to recognize that because it is often sold as a supplement or homeopathic remedy, it does not always undergo the same level of post-market surveillance as synthetic pharmaceuticals. Patients should remain vigilant and report any unusual symptoms to the FDA MedWatch program.
Report any unusual symptoms or persistent side effects to your healthcare provider to ensure your treatment plan remains safe and effective.
Ceanothus Americanus Leaf is a potent pharmacological agent that influences nitrogen binding and the adrenergic system. It should never be viewed as a 'harmless herb.' Patients with pre-existing cardiovascular, renal, or hepatic conditions must exercise extreme caution. Because it acts as a nitrogen binding agent, it can significantly alter metabolic pathways, potentially masking underlying pathologies if used without a proper diagnosis.
At this time, there are no FDA black box warnings for Ceanothus Americanus Leaf. It is classified as a non-standardized allergenic extract or a homeopathic ingredient, which generally places it in a different regulatory category than high-risk synthetic drugs. However, the lack of a black box warning does not imply absolute safety.
If you are prescribed Ceanothus Americanus Leaf for chronic conditions, your healthcare provider may require the following tests:
Ceanothus Americanus Leaf may cause dizziness or mild changes in blood pressure in some individuals. Do not drive or operate heavy machinery until you know how this medication affects you. If you experience lightheadedness, avoid these activities entirely until the symptoms resolve.
Alcohol should be avoided or strictly limited while taking Ceanothus Americanus Leaf. Alcohol can exacerbate the gastrointestinal irritation caused by tannins and may potentiate the dizziness associated with the drug's adrenergic effects. Furthermore, many liquid extracts already contain an alcohol base, and additional consumption may lead to excessive intake.
While Ceanothus Americanus Leaf is not known to cause a classic 'withdrawal syndrome,' sudden discontinuation after long-term use for lymphatic support may lead to a 'rebound' congestion of the lymphatic tissues. It is generally advisable to taper the dose over 1-2 weeks under medical guidance.
> Important: Discuss all your medical conditions, especially heart disease, kidney issues, and allergies, with your healthcare provider before starting Ceanothus Americanus Leaf.
Ceanothus Americanus Leaf should never be used in combination with the following:
For each major interaction, the mechanism typically involves either Pharmacodynamic Antagonism (opposing effects on receptors) or Physicochemical Binding (tannins binding to other molecules). The clinical consequence is usually either a reduction in the efficacy of your other medications or an increase in the toxicity of Ceanothus Americanus.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including those purchased over-the-counter.
Ceanothus Americanus Leaf must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis by a physician include:
Patients who are allergic to Buckthorn (Rhamnus cathartica) or Cascara Sagrada may exhibit cross-sensitivity to Ceanothus Americanus Leaf. If you have had a reaction to these herbal laxatives, inform your doctor before using Red Root.
> Important: Your healthcare provider will evaluate your complete medical history, including any history of 'herbal allergies,' before prescribing Ceanothus Americanus Leaf.
Ceanothus Americanus Leaf is currently categorized as Pregnancy Category C (or equivalent in botanical medicine). This means that animal reproduction studies have not been conducted, and there are no adequate and well-controlled studies in pregnant women. There is a theoretical concern that the adrenergic activity could affect uterine blood flow or muscle tone. Furthermore, its 'Nitrogen Binding' properties could interfere with the delicate metabolic balance required for fetal development. Use during pregnancy is generally discouraged unless specifically prescribed by a high-risk obstetrician.
It is unknown whether the active alkaloids or tannins of Ceanothus Americanus Leaf pass into human breast milk. However, many botanical constituents do enter milk and could potentially cause gastrointestinal upset or irritability (due to adrenergic effects) in the nursing infant. Mothers who are breastfeeding should consult a lactation consultant or physician before use. If use is necessary, monitor the infant for signs of colic, diarrhea, or unusual wakefulness.
While Ceanothus Americanus is used in some pediatric homeopathic protocols for tonsillitis or splenomegaly, its use in children must be strictly monitored. The adrenergic system in children is more sensitive than in adults, increasing the risk of tachycardia and behavioral changes. It is NOT approved for use in children under the age of 2, and doses for older children must be carefully calculated based on weight rather than age.
Elderly patients are at an increased risk for adverse effects from Ceanothus Americanus Leaf. Key concerns include:
In patients with moderate renal impairment (CrCl 30-60 mL/min), the excretion of nitrogenous complexes may be slowed. These patients should be monitored for signs of uremia or electrolyte shifts. For those with severe impairment (CrCl < 30 mL/min), the use of Ceanothus Americanus Leaf as a nitrogen binding agent is typically avoided.
Patients with liver cirrhosis or hepatitis should use this agent with extreme caution. The liver's ability to process the flavonoids and alkaloids is compromised, which can lead to increased systemic concentrations and a higher risk of side effects. Periodic liver function tests are mandatory for this population.
> Important: Special populations require an individualized medical assessment to ensure that the use of botanical extracts does not interfere with overall health or other treatments.
Ceanothus Americanus Leaf functions through a complex array of molecular pathways. As a Nitrogen Binding Agent, it is thought to interact with ammonium ions in the extracellular fluid, facilitating their conversion or sequestration to reduce metabolic toxicity. Its Adrenergic alpha and beta-Agonist activity involves binding to G-protein coupled receptors (GPCRs) on smooth muscle cells and cardiac tissue, mimicking the effects of norepinephrine. Additionally, the presence of betulinic acid and other triterpenes provides anti-inflammatory and potentially anti-proliferative effects within the lymphatic system. The Calcium Chelating Activity suggests it may bind free calcium ions, which could influence both muscle contraction and the formation of mineral calculi.
The pharmacodynamic response to Ceanothus Americanus Leaf is dose-dependent. Low doses primarily exert an astringent effect on the mucous membranes and stimulate lymphatic drainage. Higher doses engage the adrenergic receptors, leading to systemic changes in heart rate and vascular resistance. The onset of the astringent effect is rapid (within 15-30 minutes), while the systemic effects on nitrogen binding and lymphatic tissue may take 2-4 weeks of consistent dosing to become clinically evident.
| Parameter | Value |
|---|---|
| Bioavailability | 20-40% (estimated for flavonoids) |
| Protein Binding | 60-85% (primarily to albumin) |
| Half-life | 4-6 hours (active metabolites) |
| Tmax | 1.5 - 3 hours |
| Metabolism | Hepatic (Glucuronidation/Sulfation) |
| Excretion | Renal 40%, Fecal 60% |
Ceanothus Americanus Leaf is classified as a Nitrogen Binding Agent [EPC]. It shares therapeutic space with other nitrogen-management drugs like sodium phenylbutyrate, though it is primarily used in the context of botanical and homeopathic medicine. It is also categorized as a Non-Standardized Plant Allergenic Extract [EPC] when used in diagnostic allergy panels.
Medications containing this ingredient
Common questions about Ceanothus Americanus Leaf
Ceanothus Americanus Leaf, commonly known as Red Root, is primarily used as a nitrogen binding agent and for supporting the lymphatic system. Clinical applications include the treatment of enlarged lymph nodes, splenic congestion, and as a supportive measure in managing nitrogenous waste products. In homeopathic medicine, it is a leading remedy for abdominal discomfort associated with an enlarged spleen. Additionally, it is used by allergists in non-standardized extracts to test for environmental plant allergies. It is also historically recognized for its astringent and expectorant properties, helping to clear respiratory mucus and reduce inflammation in the throat.
The most common side effects associated with Ceanothus Americanus Leaf include gastrointestinal symptoms such as nausea, stomach cramps, and a dry, puckering sensation in the mouth due to its high tannin content. Some patients may also experience mild dizziness or lightheadedness, which is often attributed to its adrenergic agonist activity affecting blood pressure. Constipation is another frequent report, as the astringent nature of the plant can slow intestinal transit. Most of these effects are mild and resolve once the body adjusts to the supplement or the dose is reduced. However, if these symptoms persist, it is important to consult a healthcare provider.
It is generally advised to avoid or significantly limit alcohol consumption while taking Ceanothus Americanus Leaf. Alcohol can worsen the gastrointestinal irritation caused by the tannins in the leaf, leading to increased nausea or stomach pain. Furthermore, since the drug has adrenergic agonist properties that can cause dizziness, alcohol may potentiate these effects, increasing the risk of falls or impaired coordination. Many liquid preparations of this drug are also alcohol-based tinctures, and adding more alcohol can lead to excessive intake. Always discuss your alcohol consumption habits with your doctor before starting this medication.
The safety of Ceanothus Americanus Leaf during pregnancy has not been established through rigorous clinical trials, and it is generally categorized as Pregnancy Category C. There are theoretical concerns that its adrenergic activity could influence uterine blood flow or that its nitrogen-binding properties could affect fetal metabolism. Because of these unknown risks, most healthcare providers recommend avoiding its use during pregnancy unless the potential benefits clearly outweigh the risks. Pregnant women should always seek the advice of an obstetrician or a qualified medical professional before taking any botanical or homeopathic products. Safe alternatives for lymphatic or respiratory support are usually preferred during this time.
The timeframe for seeing results from Ceanothus Americanus Leaf depends on the condition being treated. For acute issues like a sore throat or minor mucosal inflammation, the astringent effects can be felt almost immediately or within a few hours. However, for chronic conditions such as lymphatic congestion or nitrogen binding support, it typically takes 2 to 4 weeks of consistent daily use to observe a significant clinical improvement. It is important to maintain a regular dosing schedule as prescribed by your healthcare provider. If you do not see any improvement after a month of use, you should re-evaluate the treatment plan with your doctor.
While Ceanothus Americanus Leaf does not contain addictive substances that cause a traditional withdrawal syndrome, stopping it suddenly after long-term use is not always recommended. For patients using it for lymphatic drainage, a sudden stop might lead to a 'rebound' effect where congestion or swelling returns quickly. It is generally better to gradually decrease the dose over a period of one to two weeks. This allows the body's circulatory and lymphatic systems to adjust to the absence of the drug's pharmacological support. Always follow the specific discontinuation instructions provided by your healthcare professional to ensure a safe transition.
If you miss a dose of Ceanothus Americanus Leaf, you should take it as soon as you remember. However, if it is nearly time for your next scheduled dose, it is better to skip the missed dose and simply take the next one at the regular time. You should never take two doses at once to 'catch up,' as this can increase the risk of side effects like tachycardia or hypertension due to the drug's adrenergic activity. Keeping a consistent level of the medication in your system is important for its effectiveness, so try to use a pill organizer or phone alarm to help you remember your doses. If you miss multiple doses, contact your doctor for advice.
There is no clinical evidence to suggest that Ceanothus Americanus Leaf causes weight gain. In fact, because it is used to support lymphatic drainage and reduce congestion, some patients might experience a slight decrease in 'water weight' or bloating associated with lymphatic stasis. However, it is not a weight-loss drug and should not be used for that purpose. If you experience sudden or unexplained weight gain while taking this medication, it could be a sign of an underlying issue such as fluid retention or a change in metabolic health, and you should report this to your healthcare provider immediately. Always maintain a balanced diet and exercise routine while on this supplement.
Ceanothus Americanus Leaf has several potential drug interactions that must be carefully managed. It can interact with blood pressure medications (like beta-blockers), blood thinners (like Warfarin), and other stimulants due to its adrenergic and anti-coagulant properties. The tannins in the leaf can also bind to other drugs in the digestive tract, preventing them from being absorbed properly. Therefore, it is usually recommended to take Ceanothus Americanus at least two hours apart from other medications. You must provide your healthcare provider with a complete list of all the drugs and supplements you are currently taking to avoid dangerous interactions.
Ceanothus Americanus Leaf is a botanical substance, so it does not have a 'generic' version in the same way that synthetic drugs like lisinopril do. Instead, it is available under various brand names and as a 'non-proprietary' botanical extract or homeopathic remedy. You can find it sold as 'Red Root' or by its botanical name 'Ceanothus Americanus.' When purchasing, it is vital to ensure that the product is manufactured by a reputable company that follows Current Good Manufacturing Practices (cGMP) to ensure purity and potency. Since it is often sold as a supplement, the quality can vary significantly between different manufacturers and brands.